Upload Avatar (500 x 500)
Tianyuan Zhang
tianyuanzhang@zju.edu.cn
Chinese, English, Japanese
Zhejiang
Zhejiang University
Pharmaceutical Sciences
  • 2016 Ph.D. in Pharmaceutics: Zhejiang University
  • Joint Ph.D. research at Kyoto University, Japan
  • Published over 36 academic papers
  • Granted 4 Chinese invention patents
  • Received 1 software copyright
  • 2016-2022 - Zhejiang University - Postdoctoral Researcher
  • 2022-present - Zhejiang University - Distinguished Researcher, Doctoral Supervisor
Drug Targeted Delivery
Gene Delivery
Stem Cell Carrier Systems
Novel Nanomaterials
Treatment of Pulmonary Diseases
  • From mesenchymal stem cells to their extracellular vesicles: Progress and prospects for asthma therapy, Chen SH, Gao JQ, Zhang TY*, 2024
  • Lyophilizable Stem Cell-Hybrid Liposome with Long-Term Stability and High Targeting Capacity, Zhang TY#, Zheng XX#, Lin RY, Sun H, Wu HH, Zhang JS, Chen SH, Li YS, Xu DH*, Gao JQ*, 2024
  • A large-scale production of mesenchymal stem cells and their exosomes for an efficient treatment against lung inflammation, Zhang JS, Lin RY, Li YY, Wang JW, Ding HQ, Fang PF, Huang YZ, Shi J, Gao JQ, Zhang TY*, 2024
  • Recent Advances of Using Exosomes as Diagnostic Markers and Targeting Carriers for Cardiovascular Disease, Li N#, Zhang TY#, Zhu LW, Sun LB, Shao GF, Gao JQ, 2023
  • Efficient intervention for pulmonary fibrosis via mitochondrial transfer promoted by mitochondrial biogenesis, Huang T, Lin RY, Su YQ, Sun H, Zheng XX, Zhang JS, Lu XY, Zhao BQ, Jiang XC, Huang LL, Li N, Shi J, Fan XH, Xu DH, Zhang TY*, Gao JQ*
Drug Delivery Targeted Therapy Gene Therapy Stem Cells Nanomaterials Pulmonary Diseases Regenerative Medicine Nanotechnology Biomedical Engineering Therapeutics

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.